Gemmus Pharma Secures $3,300,000 Series B Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=25743886-9f1c-4855-b411-c04c279261bb
Date
5/13/2014
Company Name
Gemmus Pharma
Mailing Address
409 Illinois Avenue San Francisco, CA 94158 USA
Company Description
Gemmus Pharma is a drug development company founded in 2007 to commercialize in-licensed technology from a major pharmaceutical company. Gemmus’ lead candidate is a cardiovascular drug currently marketed in Asia that has been repurposed for use as a treatment for influenza.
Website
http://www.gemmuspharma.com
Transaction Type
Venture Equity
Transaction Amount
$3,300,000
Transaction Round
Series B
Proceeds Purposes
The company intends to use the funds to complete production and toxicology studies for an IND filing by the end of the year.
M&A Terms
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor